Cambridge Investment Research Advisors’s CyrusOne Inc Common Stock CONE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,774
| Closed | -$697K | – | 3363 |
|
|
2021
Q4 | $697K | Sell |
7,774
-900
| -10% | -$76.4K | ﹤0.01% | 1838 |
|
|
2021
Q3 | $671K | Sell |
8,674
-870
| -9% | -$65.4K | ﹤0.01% | 1818 |
|
|
2021
Q2 | $683K | Buy |
9,544
+117
| +1% | +$8.52K | ﹤0.01% | 1814 |
|
|
2021
Q1 | $638K | Sell |
9,427
-59
| -0.6% | -$4.09K | ﹤0.01% | 1714 |
|
|
2020
Q4 | $694K | Sell |
9,486
-1,887
| -17% | -$137K | ﹤0.01% | 1553 |
|
|
2020
Q3 | $796K | Sell |
11,373
-25
| -0.2% | -$1.96K | 0.01% | 1319 |
|
|
2020
Q2 | $829K | Sell |
11,398
-459
| -4% | -$32.7K | 0.01% | 1233 |
|
|
2020
Q1 | $732K | Buy |
11,857
+787
| +7% | +$48.1K | 0.01% | 1143 |
|
|
2019
Q4 | $724K | Buy |
11,070
+2,408
| +28% | +$165K | 0.01% | 1344 |
|
|
2019
Q3 | $685K | Buy |
8,662
+772
| +10% | +$51.5K | 0.01% | 1293 |
|
|
2019
Q2 | $455K | Buy |
7,890
+2,181
| +38% | +$128K | ﹤0.01% | 1490 |
|
|
2019
Q1 | $299K | Buy |
+5,709
| New | +$299K | ﹤0.01% | 1807 |
|
|
2018
Q4 | – | Sell |
-4,187
| Closed | -$265K | – | 2321 |
|
|
2018
Q3 | $265K | Sell |
4,187
-168
| -4% | -$10.9K | ﹤0.01% | 1875 |
|
|
2018
Q2 | $254K | Sell |
4,355
-779
| -15% | -$42.2K | ﹤0.01% | 1854 |
|
|
2018
Q1 | $263K | Sell |
5,134
-149
| -3% | -$7.98K | ﹤0.01% | 1770 |
|
|
2017
Q4 | $315K | Sell |
5,283
-240
| -4% | -$14.6K | ﹤0.01% | 1624 |
|
|
2017
Q3 | $325K | Buy |
+5,523
| New | +$329K | ﹤0.01% | 1498 |
|
Other funds holding CONE
Cambridge Investment Research Advisors's CONE Position: Q1 2022 in Review
Cambridge Investment Research Advisors sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 7,774 shares — an estimated $697K sold.
Cambridge Investment Research Advisors first reported a position in CONE in Q3 2017 and held it in 17 quarters. The position peaked at $829K in Q2 2020. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.
- Cambridge Investment Research Advisors reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 7,774 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $697K.
- Cambridge Investment Research Advisors first reported a position in CyrusOne Inc Common Stock in Q3 2017 and held it in 17 quarters.
- Cambridge Investment Research Advisors's CyrusOne Inc Common Stock position peaked at $829K in Q2 2020.
- 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2022, filed 12 May 2022.